Stem cell treatment for knee cartilage damage
Part of Bones, joints & muscles clinical trials.
This trial tests whether a new stem cell treatment, given during a surgical procedure, can help repair damaged cartilage in the knee. It is for people with moderate to severe knee pain and a specific size of cartilage injury.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You are scheduled for surgery to repair damaged knee cartilage.
- The damaged area is 2 to 6 square centimeters on your thighbone, kneecap, or groove.
- Your knee pain is moderate to severe (score below 70) without pain medication, and your other knee is nearly pain-free.
- You do not have severe arthritis, major knee instability, or certain other health problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment that uses your own bone marrow cells to grow a piece of tissue to repair damaged knee cartilage. It's for people with a single, medium-sized cartilage injury on the thigh bone part of the knee joint that hasn't gotten better with other treatments.
This early-phase study tests whether a special liquid made from stem cells, combined with a protein-rich blood product, can help repair damaged knee cartilage. If you have early osteoarthritis, this might reduce pain and improve knee function.
This trial tests if a cell-based treatment called CARTISTEM can repair knee cartilage better than surgery alone. It involves people with knee osteoarthritis and a cartilage defect, with moderate pain and limited function.
This trial tests a new cell-based treatment (CLS2901C) for knee osteoarthritis. It combines the treatment with a realignment surgery (proximal tibial osteotomy) to help repair cartilage damage and reduce pain.
This study tests a new implant made from your own cells to repair damaged knee cartilage. It aims to reduce pain and improve knee function by replacing the damaged area with a living implant.
This study tests whether special stem cells (called UC-MSCs, derived from umbilical cord tissue) can reduce pain and improve function in people with moderate knee osteoarthritis. Researchers will inject these cells into your knee to see if they help repair damaged cartilage and reduce inflammation.
Hear when a new Cartilage Damage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.